Related Experiment Video
Updated: Jul 20, 2026

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
Mario Berth1, Eugene Bosmans, Jacques Everaert
1Immunology Department, Algemeen Medisch Laboratorium, Antwerpen, Belgium. mario.berth@aml-lab.be
Insights
High rheumatoid factor can interfere with carbohydrate antigen 19-9 (CA 19-9) tests, particularly on the ADVIA Centaur system. Further testing with alternative methods is recommended if results are clinically questionable.
Area of Science:
- Clinical Chemistry
- Laboratory Medicine
- Diagnostic Assays
Background:
- A patient presented with fatigue and weight loss, showing an elevated carbohydrate antigen 19-9 (CA 19-9) level of 80 kU/L on an ADVIA Centaur analyser.
- Simultaneously, high rheumatoid factor (RF) levels (900 kIU/L) were detected, raising suspicion of assay interference.
Purpose of the Study:
- To investigate and estimate the frequency of rheumatoid factor interference in carbohydrate antigen 19-9 (CA 19-9) assays.
- To compare CA 19-9 results across different laboratory platforms when high RF is present.
Main Methods:
- A multicenter study evaluated four CA 19-9 methods using samples with high RF concentrations.
- A second study used heterophilic blocking tubes on samples with varying CA 19-9 levels analyzed by ADVIA Centaur.
Main Results:
- One case of clear RF interference was identified in the multicenter study, with other discrepancies attributed to method variations.
- No interference was detected using heterophilic blocking tubes in routine samples analyzed by ADVIA Centaur.
Conclusions:
- The ADVIA Centaur system shows higher sensitivity to rheumatoid factor interference in CA 19-9 testing.
- Lack of standardization in CA 19-9 assays persists; using a single method for patient follow-up is advised.
- Confirming questionable CA 19-9 results with an alternative method is crucial to rule out interference.
Background:
Investigation of a 61-year-old Caucasian male suffering from fatigue and weight loss led to the finding of a carbohydrate antigen 19-9 (CA 19-9) concentration of 80 kU/L using an ADVIA Centaur analyser. Determination of CA 19-9 on Vidas, AxSYM and Architect i2000 systems gave normal results. His rheumatoid factor concentration was very high (900 kIU/L) and assay interference was suspected.
Methods:
Besides using several laboratory procedures to show the cause of the interference, we tried to estimate the frequency of the suspected interference. Therefore, two studies were performed. The first was carried out in a multicentre setting using four different CA 19-9 methods on 51 randomly selected samples with high rheumatoid factor concentrations and ten samples containing no or very low rheumatoid factor. In the second study we used heterophilic blocking tubes for 68 routinely analysed samples with CA 19-9 concentrations ranging between 37 and 250 kU/L using an ADVIA Centaur analyser.
Results:
In the multicentre study we found eight discrepant CA 19-9 results, but only one was clearly due to interference. We showed that the interference detected, just as in the index case, was caused by rheumatoid factor. The other discrepancies could not be explained, but are probably related to method-dependent differences. In the 68 routinely analysed samples, no interference could be shown using the heterophilic blocking tubes.
Conclusions:
Although interferences in the CA 19-9 assay are not frequent, the ADVIA Centaur system appears to be more sensitive to rheumatoid factor interference. The lack of standardisation remains an important issue for this assay. The determination of CA 19-9 during the follow-up of patients should be performed using a single method. If, however, there is any clinical doubt about a result, CA 19-9 should be determined using another method to exclude possible interferences.
More Related Videos
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011